KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Retained Earnings (2019 - 2025)

GoodRx Holdings' Retained Earnings history spans 7 years, with the latest figure at -$1.4 billion for Q3 2025.

  • For Q3 2025, Retained Earnings rose 2.19% year-over-year to -$1.4 billion; the TTM value through Sep 2025 reached -$1.4 billion, up 2.19%, while the annual FY2024 figure was -$1.4 billion, 1.12% up from the prior year.
  • Retained Earnings for Q3 2025 was -$1.4 billion at GoodRx Holdings, roughly flat from -$1.4 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at -$1.4 billion in Q2 2021 and bottomed at -$1.5 billion in Q1 2024.
  • The 5-year median for Retained Earnings is -$1.4 billion (2025), against an average of -$1.4 billion.
  • The largest annual shift saw Retained Earnings fell 25.97% in 2021 before it rose 2.38% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$1.4 billion in 2021, then dropped by 2.32% to -$1.4 billion in 2022, then decreased by 0.61% to -$1.5 billion in 2023, then increased by 1.12% to -$1.4 billion in 2024, then grew by 1.74% to -$1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Retained Earnings are -$1.4 billion (Q3 2025), -$1.4 billion (Q2 2025), and -$1.4 billion (Q1 2025).